ShareValue scores for BFRI: Valuation 53, Quality 41, Growth 54, Health 46.
BFRINASDAQ
Biofrontera Inc
$1.25
(+0.81%)
BFRINASDAQ
Biofrontera Inc
$1.25(+0.81%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 17%
Rating
Trap Risk
Return
6% to 17%
Valuation
53
Fair Value
Price vs Value
Quality
41
Moderate
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
46
Moderate
Financial Stability
Momentum
67
Bullish
Price Trend
Company Details
About
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Address: 660 Main Street, Woburn, MA, United States, 01801
Market Cap$16M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1490
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026